Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma

Author: Choi Brian   Sondel Paul   Hank Jacquelyn   Schalch Heidi   Gan Jacek   King David   Kendra Kari   Mahvi David   Lee Li-Yin   Kim KyungMann   Albertini Mark  

Publisher: Springer Publishing Company

ISSN: 0340-7004

Source: Cancer Immunology, Immunotherapy, Vol.55, Iss.7, 2006-07, pp. : 761-774

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content